Biomm SA (Brazil) Insiders
| BIOM3 Stock | BRL 8.88 0.22 2.42% |
Biomm SA employs about 148 people. The company is managed by 10 executives with a total tenure of roughly 18 years, averaging almost 1.0 years of service per executive, having 14.8 employees per reported executive. Breaking down Biomm SA's management performance can provide insight into the firm performance.
| Francisco Freitas CEO Chief Executive Officer, Member of the Executive Board |
| Guilherme Emrich Chairman Chairman of the Board |
Biomm |
Biomm SA Management Team Effectiveness
The company has return on total asset (ROA) of (0.1539) % which means that it has lost $0.1539 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7655) %, meaning that it generated substantial loss on money invested by shareholders. Biomm SA's management efficiency ratios could be used to measure how well Biomm SA manages its routine affairs as well as how well it operates its assets and liabilities.Biomm SA Workforce Comparison
Biomm SA is rated fifth in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 27,553. Biomm SA maintains roughly 148 in number of employees contributing less than 1% to equities under Health Care industry.
The company has Profit Margin (PM) of (0.99) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.9) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.9. Biomm SA Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Biomm SA Price Series Summation is a cross summation of Biomm SA price series and its benchmark/peer.
Biomm SA Notable Stakeholders
A Biomm SA stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Biomm SA often face trade-offs trying to please all of them. Biomm SA's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Biomm SA's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Francisco Freitas | Chief Executive Officer, Member of the Executive Board | Profile | |
| Guilherme Emrich | Chairman of the Board | Profile | |
| Roberto Carvalho | Director | Profile | |
| Walfrido Guia | Independent Director | Profile | |
| Italo Gaetani | Director | Profile | |
| Douglas Lopes | Strategic Planning Director, PMO and Member of The Executive Board | Profile | |
| Luciano Villela | Member of the Executive Board | Profile | |
| Heraldo Marchezini | CEO Board | Profile | |
| Mirna Vieira | Investor CFO | Profile | |
| Francisco Costa | Commercial Board | Profile |
About Biomm SA Management Performance
The success or failure of an entity such as Biomm SA often depends on how effective the management is. Biomm SA management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Biomm management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Biomm management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
It offers AFREZZA, a human insulin inhalation powder CONFORT CARE, a moisturizing foot cream GLARGILIN, a glargine insulin and HERZUMA, a trastuzumab. Biomm S.A. was founded in 2001 and is based in So Paulo, Brazil. BIOMM ON operates under Biotechnology classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 94 people.
Please note, the imprecision that can be found in Biomm SA's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Biomm SA. Check Biomm SA's Beneish M Score to see the likelihood of Biomm SA's management manipulating its earnings.
Biomm SA Workforce Analysis
Traditionally, organizations such as Biomm SA use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Biomm SA within its industry.Biomm SA Manpower Efficiency
Return on Biomm SA Manpower
| Revenue Per Employee | 723.6K | |
| Revenue Per Executive | 10.7M | |
| Net Loss Per Employee | 542.3K | |
| Net Loss Per Executive | 8M | |
| Working Capital Per Employee | 277K | |
| Working Capital Per Executive | 4.1M |
Additional Tools for Biomm Stock Analysis
When running Biomm SA's price analysis, check to measure Biomm SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomm SA is operating at the current time. Most of Biomm SA's value examination focuses on studying past and present price action to predict the probability of Biomm SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomm SA's price. Additionally, you may evaluate how the addition of Biomm SA to your portfolios can decrease your overall portfolio volatility.